Showing 1 - 10 of 25
More Than a Cure: The Complex Journey of Pediatric Bone Marrow Transplantation
Published on 31/03/2026
» For most families, the journey toward a bone marrow transplant does not begin with a clear plan. It begins with uncertainty — a diagnosis that raises more questions than answers, repeated hospital visits and the growing realization that their child’s illness is more complex than initially understood.
Pfizer Thailand Reaffirms Commitment to Expanding Access to Innovative Medicines
Published on 11/12/2024
» This year, Pfizer globally celebrated its 175 years. This milestone is not just a celebration of longevity but a testament to the company's unwavering dedication to improving global health. In Thailand, the company has been a significant contributor to the healthcare landscape for over six decades.
Building wealth through health
Business, Kean Tan, Published on 30/05/2024
» Financial markets price the future. About a year ago, the market was looking for an aggressive reversal of interest rates, reflecting the turmoil in the US banking system and the expectation of an economic slowdown.
Pfizer buys biotech firm Seagen for $43 billion
AFP, Published on 13/03/2023
» WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
Innobic allocates B1bn for investments
Business, Yuthana Praiwan, Published on 18/01/2023
» Innobic (Asia), the life science arm of national oil and gas conglomerate PTT Plc, plans to spend 1 billion baht in capital expenditure this year to support cancer medicine and plant-based protein factory development projects.
Firms rejig to survive in lean times
Business, Phusadee Arunmas, Yuthana Praiwan and Lamonphet Apisitniran, Published on 07/06/2022
» Businesses adopted cost reduction, increased productivity, and emphasised environmental standards to cope with the pandemic and global challenges stemming from the Russia-Ukraine war, panellists told the Forbes Thailand 2022 Forum on Monday.
Post-pandemic healthcare
Asia focus, Published on 16/05/2022
» Health crises and emergencies such as Covid-19 have brought into sharp focus the critical need for preparedness. The unprecedented pandemic has led to a dynamically changing environment across the healthcare industry, posing challenges that call for innovative solutions.
Testament to protecting millions of lives
Business, Janine Phakdeetham, Published on 24/03/2022
» The race against time to safely develop and quickly deliver a life-saving COVID-19 vaccine around the world serves as AstraZeneca's testament to protecting the lives of billions of people while addressing one of the biggest healthcare crises facing humankind.
Drugmakers Reap Billions Meeting Covid-19 Needs
Business, Peter Loftus, Published on 28/02/2022
» Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.
Pfizer sees Covid-19 drug sales topping $50bn in 2022
AFP, Published on 09/02/2022
» NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.